Presidio Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery of small-molecule antiviral therapeutics.
Business Model:
Revenue: $4.4M
Employees: 51-200
Presidiopharma was acquired by
BioCryst Pharmaceuticals.
The acquisition happend on 2012-10-18.
Details of the transaction were not public
Address: 1700 Owens St
City: San Francisco
State: CA
Zip: 94158
Country: US
Presidio Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery of small-molecule antiviral therapeutics.
Contact Phone:
+14156557560
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2012 | Venture Round | $14.4M | 7/2009 | Venture Round | 1 | $27M |
New Leaf Venture Partners New Leaf Venture Partners New Leaf Venture Partners New Leaf Venture Partners |
6/2014 | Series D | $21.8M | 3/2006 | Series A | 1 | - |
Sagamore Bioventures Sagamore Bioventures |
10/2012 | Venture Round | 3 | $8M |
Panorama Capital New Leaf Venture Partners Baker Brothers Advisors LLC Panorama Capital New Leaf Venture Partners Baker Brothers Advisors LLC |
7/2011 | Debt Financing | $3M | 4/2013 | Series D | $21.8M | 8/2007 | Series B | 5 | $26M |
Bay City Capital Nexus Medical Partners Ventures West Baker Brothers Advisors LLC Panorama Capital Panorama Capital Bay City Capital Nexus Medical Partners Ventures West Baker Brothers Advisors LLC Panorama Capital Panorama Capital |
3/2006 | Series A | 1 | - |
Sagamore Bioventures Sagamore Bioventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|